Pinpoint Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-4,050
Closed -$3.59M 115
2024
Q3
$3.59M Buy
4,050
+841
+26% +$756K 0.77% 22
2024
Q2
$2.91M Buy
3,209
+247
+8% +$198K 0.41% 32
2024
Q1
$2.3M Buy
+2,962
New +$2.11M 0.37% 41

Other funds holding LLY

Pinpoint Asset Management's LLY Position: Q4 2024 in Review

Pinpoint Asset Management sold out of Eli Lilly (LLY) in Q4 2024, closing a stake of 4,050 shares — an estimated $3.59M sold.

Pinpoint Asset Management first reported a position in LLY in Q1 2024 and held it in 3 quarters. The position peaked at $3.59M in Q3 2024. 3,907 funds tracked by Wall St. Rank hold LLY as of Q4 2024.

  • Pinpoint Asset Management reported no remaining Eli Lilly position as of Q4 2024 after selling out during the quarter.
  • Pinpoint Asset Management sold 4,050 Eli Lilly shares in Q4 2024, an estimated $3.59M.
  • Pinpoint Asset Management first reported a position in Eli Lilly in Q1 2024 and held it in 3 quarters.
  • Pinpoint Asset Management's Eli Lilly position peaked at $3.59M in Q3 2024.
  • 3,907 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2024.

Based on Pinpoint Asset Management's 13F filing for Q4 2024, filed 13 Feb 2025.